View Author
patient stent lesion study follow-up angioplasty group restenosi angiographic month event artery balloon angioplasty balloon analysis outcome calci trial women calci fied group procedure diameter vessel intervention result noncalci fied group table angina infarction stent implantation implantation survival stenting disease 6 months spirit percutaneou ⅐⅐⅐ cardiol angiography circulation noncalci artery disease treatment death benestent surgery target spirit ii 3 years symptom serruy percutaneous transluminal stenosi revascularization heart difference calci fied diabetes in-stent signi deployment randomized stent deployment coll cardiol value factor thrombosis 1 year reference number signi ficantly calci fied lesions point stent thrombosis transluminal ef ficacy variable predictor end points
10 Most Recent Publications
|
Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: A pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE v Everolimus Eluting Coronary Stent System in the Treatment of Patients with de Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE v Everolimus Eluting Coronary Stent System [EECSS]
(Article)
Caixeta, A. Lansky, A.J. Sood, P. Su, X. Jonnavithula, L. Sudhir, K. Stone, G.W. Serruys, P.W.J.C. Hermiller, J.B. Ruygrok, P.N. Onuma, Y. Gordon, P. Yaqub, M. Miquel-Hébert, K. Veldhof, S. |
2010-12-01
|
|
Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: Two-year angiographic and three-year clinical results from the SPIRIT II study
(Article)
Onuma, Y. Tanimoto, S. Thuesen, L. Dorange, C. Miquel, K. Veldhof, S. Serruys, P.W.J.C. Ruygrok, P.N. Neuzner, J. Piek, J.J. Seth, A. Schofer, J. Richardt, G. Wiemer, M. Carrié, D. |
2010-11-01
|
|
Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients.
(Article)
West, N.E. Ruygrok, P.N. Disco, C. Webster, M.W.I. Lindeboom, W.K. O'Neill, W.W. Mercado, N.F. Serruys, P.W.J.C. |
2004-02-24
|
|
Clinical and Angiographic Factors Associated With Asymptomatic Restenosis After Percutaneous Coronary Intervention
(Article)
Ruygrok, P.N. Webster, M.W.I. Valk, V. de Es, G.A. van Ormiston, J.A. Morel, M-A.M. Serruys, P.W.J.C. |
2001-01-01
|
|
Does angiography six months after coronary intervention influence management and outcome? Benestent II Investigators.
(Article)
Ruygrok, P.N. Melkert, R. Morel, M-A.M. Ormiston, J.A. Bär, F.W.H.M. Suryapranata, H. Dawkins, K.D. Hanet, C. Serruys, P.W.J.C. Fernandez-Avilez, F. |
1999-01-01
|
|
Women fare no worse than men 10 years after attempted coronary angioplasty.
(Article)
Ruygrok, P.N. Domburg, R.T. van Serruys, P.W.J.C. Brand, M.J.B.M. van den Feyter, P.J. de Jaegere, P.P.T. de |
1996-09-01
|
|
Clinical outcome 10 years after attempted percutaneous transluminal coronary angioplasty in 856 patients.
(Article)
Ruygrok, P.N. Domburg, R.T. van Serruys, P.W.J.C. Brand, M.J.B.M. van den Feyter, P.J. de Jaegere, P.P.T. de |
1996-06-01
|
|
Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group.
(Article)
Macaya Miguel, C.M. Serruys, P.W.J.C. Crean, P.A. Bonnier, J.J.R.M. Wijns, W. Danchin, N. Bourdonnec, C. Morel, M-A.M. Mast, E.G. Ruygrok, P.N. Suryapranata, H. Klugmann, S. Urban, P. Heijer, P. den Koch, K. Simon, R. Morice, M-C. |
1996-02-01
|
|
Heparin-coated Palmaz-Schatz Stents in Human Coronary Arteries. .
(Article)
Serruys, P.W.J.C. Emanuelsson, H.U. Materne, P.H. Bonnier, J.J.R.M. Morice, M-C. Fajadet, J. Belardi, J.A. Colombo, A. Garcia, E. Ruygrok, P.N. Morel, M-A.M. Giessen, W.J. van der Lunn, A.C. Jaegere, P.P.T. de Kiemeneij, F. Macaya Miguel, C.M. Rutsch, W.R. Heyndrickx, G.R. Suryapranata, H. Legrand, V.M.G. Goy, J-J. |
1996-01-01
|
|
Acute clinical and angiographic results with the new AVE Micro coronary stent in bailout management.
(Article)
Ozaki, Y. Keane, D.T.J. Ruygrok, P.N. Stertzer, S. Serruys, P.W.J.C. Feyter, P.J. de |
1995-07-27
|
